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Abstract: The first total synthesis of mycalisine A, a pyrrolo[2,3-dlpyrimidine nucleoside, was 
accomplished by a multi-step synthesis from toyocamycin. 
A search for bioactive marine metabolites has resulted in the isolation of an unusual compound from 
a lipophilic extract of a marine sponge m sp.’ This compound, mycalisine A, was found to inhibit the 
cell division of fertilized starfish eggs. Additional studies established that mycalisine A was a 
pyrrolo[2,3_d]pyrimidine nucleoside with unsaturation between the 4’ and 5’-positions of the ribose 
moiety.’ A number of structurally related pyrrolo[2,3_d]pyrimidine nucleosides have been previously 
isolated from naturally occurring sources2, as well as prepared3 by synthetic procedures. These 
pyrrolo[2,3-dlpyrimidine nucleosides have exhibited some very interesting biological and 
chemotherapeutic activities 4’5. This prompted us to initiate a study designed to provide the first total 
synthesis of mycalisine A. 
After the evaluation of several retrosynthetic approaches for the synthesis of mycalisine A, we 
elected to use an approach where the nucleoside antibiotic toyocamycin was our starting material. 
Toyocamycin (I) was methylated’ with diazomethane and a catalytic amount of SnC12. The solid which was 
isolated from the reaction mixture proved to be a mixture of the P’-Q-methyl and 3’-Q-methyl isomers 
(2&b). That the actual site of methylation was on an oxygen of the carbohydrate moiety in both isomers, 
was determined by the chemical shifts observed for the methyl protons in the ‘H NMR (6 3.31 and 3.38). 
This assignment was supported by the UV spectrum of 26.b which was essentially unchanged in comparison 
to the UV spectrum of toyocamycin. Integration of the peaks corresponding to the anomeric protons 
revealed a 60:40 ratio of regioisomers. In contrast to a previous report,’ we could not improve on the 
regioselectivity of the methylation by using different Lewis acids. Separation of the regioisomers was not 
achieved by silica gel chromatography, reverse phase HPLC, or by recrystallization from a number of 
solvents. The use of a Dowex ion-exchange column was also excluded because of the known lability of the 
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The separation of regioisomers was achieved by acetylating the mixture (2&b) with acetic 
anhydride and a catalytic amount of DMAP to afford the acetylated mixture &.b, as determined by ‘H NMR. 
A single recrystallization of the mixture from toluene afforded a solid, 90% of which appeared to be a 
single isomer as judged by TLC. This enriched solid was deblocked using methanolic ammonia. A single 
regioisomer of 2 was isolated,’ after recrystallization of the crude product from MeOH. This isomer was 
identified as the desired 3’-Q-methyl isomer (2a) on the basis of the intense B+30 peak in the mass 
spectra. This peak has been shown to be characteristic of the 3’-Q-methyl regioisomer of purine and 
purine-like ribosides.6’1 ’ 
Unsaturation at the 4’5’ position of 3’-Q-methyltoyocamycin (2.a) was accomplished using a 
modification of a literature procedure. 11 Treatment of 2.9 with 3 equivalents each of Q- 
nitrophenylselenocyanate 12 and tributyl phosphine afforded the desired9 S-selenide derivative 4. The 
site of attachment for the Q-nitrophenylselenide group was shown to be at the 5’ position by ‘H NMR 
analysis of the 5’ methylene protons. In the ‘H NMR spectrum of Z& the peaks corresponding to the 5 
methylene protons were observed as a multiplet centered at 6 3.6. Upon conversion to the selenide 4, these 
protons appeared as a doublet which was centered upfield at 6 3.4. 
The selenide 4 was then oxidized to afford the presumed epimeric selenoxldes m using an excess 
of a Na104 in water-THF solution. After evaporation of the solvent, the crude reaction concentrate was 
suspended in pyridine and the excess Na104 was removed by filtration. The filtrate was treated with one 
equivalent of Et3N and heated at 50°C for 5 hours. Removal of the solvent and column chromatography of 
the resulting residue afforded a white crystalline solid, 35.4% yield from 4. The 270 MHz ‘H NMR, UV, 
and mass spectral data obtained for this compound l3 was essentially identical to that reported’ for 
mycalisine A (6). 
In conclusion, we have developed a total synthesis of the naturally occurring pyrrolo 
[2,3-djpyrimidine nucleoside mycalisine A. 
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